Extendicare Inc. (TSE:EXE – Get Rating) – Investment analysts at National Bank Financial dropped their FY2024 earnings per share estimates for Extendicare in a research report issued to clients and investors on Monday, March 6th. National Bank Financial analyst T. Woolley now forecasts that the company will earn $0.34 per share for the year, down from their prior forecast of $0.45. The consensus estimate for Extendicare’s current full-year earnings is $0.23 per share.
EXE has been the subject of a number of other research reports. Royal Bank of Canada lowered their price objective on Extendicare from C$7.50 to C$7.00 and set a “sector perform” rating for the company in a research report on Monday. National Bankshares lowered their price objective on Extendicare from C$7.50 to C$7.00 and set a “sector perform” rating on the stock in a report on Monday, January 30th.
Extendicare Stock Down 0.8 %
Extendicare Announces Dividend
The business also recently announced a monthly dividend, which will be paid on Wednesday, March 15th. Stockholders of record on Tuesday, February 28th will be issued a $0.04 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 7.48%. The ex-dividend date of this dividend is Monday, February 27th. Extendicare’s payout ratio is currently -960.00%.
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties.
- Fossil Group: Should You Bet On Consumer Discretionary In 2023?
- BJ’s Wholesale Club Stock Moves Higher After Strong Results
- Monthly Realty Income is About to Get Bigger
- 3 Large Cap Dividend Challengers for Millennial Investors
- Sea Ltd Is On The Verge Of A 100% Rally, Should You Buy?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.